Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a ...

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Gains from its Bitcoin holdings contributed notably to EPS growth. Semler Scientific produces the QuantaFlo -- a non-invasive ...

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

What is Peripheral Vascular Disease? Symptoms and Causes Explained - Peripheral Vascular Disease, PVD for short, is a ...

They also looked at the MSK-Frailty Index, a composite measure of the following clinical risk factors: chronic obstructive ...

Coronary artery disease is the silent killer because you can have it for years and have no symptoms until it’s too late.